(THRX:Consolidated Issue Listed on NASDAQ Global Select )
Mathai Mammen M.D., Ph.D.
Co-Founder, Theravance Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
As of Fiscal Year 2014
Dr. Mathai Mammen, M.D., Ph.D. has been Senior Vice President of Research & Development at Theravance Biopharma, Inc. since October 2014. Dr. Mammen Co-founded Theravance Inc. in 1996, and served as its Senior Vice President of Research & Early Clinical Development since February 2009 until September 30, 2014. Dr. Mammen served as Senior Vice President of Research of Theravance Inc. since April 2008. Dr. Mammen served as Vice President of Theravance's Molecular and Cellular ...
951 Gateway BoulevardPhone: 650-238-9600
South San Francisco, California 94080
Board Members Memberships*There is no Board Members Memberships data available.
Harvard Medical School
Department of Chemistry&Chemical Biology, Harvard University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Clive A. Meanwell M.D., Ph.D.||Chairman and Chief Executive Officer|
The Medicines Company
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|$1.5M||Compensation as of Fiscal Year 2014.|